OMEPRAZOLE EXTENDED
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F3833 for the supply of OMEPRAZOLE EXTENDED, identified by NSN 6505016247068, as part of a delivery order under the parent contract SPE2DX25D9900. The award was issued on March 26, 2026, with the total contract price specified in the award documentation, and the item is intended for federal use under the Department of Defense. The solicitation was posted on DIBBS on July 21, 2026, and the contract is classified as a federal award with no set-aside designation. Performance location and point of contact details are not provided, but the award is managed through the DLA and accessible via the official DIBBS portal.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(3)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
